President Donald Trump announces Medicaid drug pricing model for all 50 states

President Donald Trump announced that all 50 states will join a new Medicaid drug pricing program aimed at aligning U.S. drug prices with those in other affluent countries. While the administration claims this could lead to significant savings, the specifics of the agreements with pharmaceutical companies are not publicly available, leading to skepticism about the actual benefits. Independent confirmation of these claims remains limited.